Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 23079502)

1.

Renin-angiotensin system, hypertension, and chronic kidney disease: pharmacogenetic implications.

Santos PC, Krieger JE, Pereira AC.

J Pharmacol Sci. 2012;120(2):77-88. Review.

2.

Renin Angiotensin System Blocker Fetopathy: A Midwest Pediatric Nephrology Consortium Report.

Nadeem S, Hashmat S, Defreitas MJ, Westreich KD, Shatat IF, Selewski DT, Onder AM, Chiang M, Weaver DJ Jr, Steinke J, Barcia J, Hernandez J, Hidalgo G, Ingraham SE, Abitbol CL, Pan C, Greenbaum LA.

J Pediatr. 2015 Jun 27. pii: S0022-3476(15)00553-3. doi: 10.1016/j.jpeds.2015.05.045. [Epub ahead of print]

PMID:
26130112
3.

Underprescription of Renin-Angiotensin system blockers in moderate to severe chronic kidney disease.

Shirazian S, Grant CD, Mujeeb S, Sharif S, Kumari P, Bhagat M, Mattana J.

Am J Med Sci. 2015 Jun;349(6):510-5. doi: 10.1097/MAJ.0000000000000475.

PMID:
26030613
4.

Combination therapy in chronic kidney disease?

Juncos LI, Caputo J.

Ther Adv Cardiovasc Dis. 2015 Apr 15. pii: 1753944715579628. [Epub ahead of print] Review.

PMID:
25882750
5.
6.

The effect of renin-angiotensin system blockade on renal protection in chronic kidney disease patients with hyperkalemia.

Lee JH, Kwon YE, Park JT, Lee MJ, Oh HJ, Han SH, Kang SW, Choi KH, Yoo TH.

J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):491-7. doi: 10.1177/1470320313507122. Epub 2014 Aug 20.

PMID:
25143329
7.

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease.

Tomiyama H, Yamashina A.

Int J Hypertens. 2014;2014:919256. doi: 10.1155/2014/919256. Epub 2014 Jan 30. Review.

8.

[The role of arterial hypertension in developement of chronic renal failure].

Kes P, Basić-Jukić N, Ljutić D, Brunetta-Gavranić B.

Acta Med Croatica. 2011 Oct;65 Suppl 3:78-84. Review. Croatian.

PMID:
23120821
9.

Blood pressure control in patients with chronic kidney disease.

Utsumi K, Katsura K, Iino Y, Katayama Y.

J Nippon Med Sch. 2012;79(2):111-4. Review.

10.

Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.

Zeymer U, Dechend R, Deeg E, Kaiser E, Senges J, Pittrow D, Schmieder R; 3A Registry Investigators.

Int J Clin Pract. 2012 Mar;66(3):251-61. doi: 10.1111/j.1742-1241.2012.02893.x. Epub 2012 Feb 9.

PMID:
22321062
11.

Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population.

Su SL, Lu KC, Lin YF, Hsu YJ, Lee PY, Yang HY, Kao SY.

J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):148-54. doi: 10.1177/1470320311430989. Epub 2011 Dec 6.

PMID:
22147663
12.

Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response.

Gonçalves AR, Khwaja A, Ahmed AK, El Kossi M, El Nahas M.

Nephron Clin Pract. 2011;119(4):c348-54.

PMID:
22135795
13.

Relationship between hyperuricemia and chronic kidney disease.

Ohno I.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1039-44. doi: 10.1080/15257770.2011.611484.

PMID:
22132954
14.

[Hypertension complicated with chronic kidney disease].

Koizumi K, Ito S.

Nihon Rinsho. 2011 Nov;69(11):2015-9. Japanese.

PMID:
22111323
15.

Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis.

Daien V, Duny Y, Ribstein J, du Cailar G, Mimran A, Villain M, Daures JP, Fesler P.

Am J Hypertens. 2012 Jan;25(1):126-32. doi: 10.1038/ajh.2011.180. Epub 2011 Oct 13. Review.

PMID:
21993366
16.

[Slowing chronic kidney disease progression: hopes and disappointments. Vascular repair of chronic kidney].

Boffa JJ, Chauvet S, Mihout F.

Presse Med. 2011 Nov;40(11):1065-73. doi: 10.1016/j.lpm.2011.06.022. Epub 2011 Sep 1. French.

PMID:
21889290
17.

What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?

de la Sierra A, Salazar J.

Adv Ther. 2011 Sep;28(9):716-27. doi: 10.1007/s12325-011-0049-6. Epub 2011 Jul 29. Review.

PMID:
21809181
18.
19.

Renal protection with angiotensin receptor blockers: where do we stand.

Schmieder RE, Ruilope LM, Barnett AH.

J Nephrol. 2011 Sep-Oct;24(5):569-80. doi: 10.5301/JN.2011.6445. Review.

PMID:
21404225
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk